30 Mar 23
A pharma company in-licensed a new product in the final stages of regulatory approval but had no medical affairs team to support product launch.
tranScrip assembled a team comprising a medical affairs physician, a medical information specialist, a medical writer and a project manager to support peri-launch.
The product was launched as planned and a phase IV clinical trial programme was designed and initiated.
Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.